| RS2139504287 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS2139505830 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS2139506946 |
ZEB1
|
Health Risk |
Likely pathogenic |
Posterior polymorphous corneal dystrophy, Posterior polymorphous corneal dystrophy |
| RS2139511447 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, SPTB-related disorder |
| RS2139513700 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139514134 |
NALCN
|
Health Risk |
Likely pathogenic |
Congenital contractures of the limbs and face, hypotonia |
| RS2139519168 |
NALCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital contractures of the limbs and face, hypotonia |
| RS2139519333 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2139527991 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS2139528052 |
OTX2
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS2139528313 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS2139528560 |
OTX2
|
Health Risk |
Pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS2139528859 |
OTX2
|
Health Risk |
Pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS2139529394 |
OTX2
|
Health Risk |
Likely pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS2139530114 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2139531134 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2139531503 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS2139531559 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2139533094 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139533161 |
SPTB
|
Health Risk |
Likely pathogenic |
SPTB-related disorder, SPTB-related disorder |
| RS2139533967 |
COL4A2
|
Health Risk |
Likely pathogenic |
— |
| RS2139534208 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS2139534321 |
COL4A2
|
Health Risk |
Likely pathogenic |
Porencephaly 2, Porencephaly 2 |
| RS2139537197 |
COL4A2
|
Health Risk |
Likely pathogenic |
Intellectual disability, Cerebral palsy |
| RS2139537621 |
TPP2
|
Health Risk |
Pathogenic |
Evans syndrome, immunodeficiency |
| RS2139538715 |
COL4A2
|
Health Risk |
Likely pathogenic |
— |
| RS2139538791 |
COL4A2
|
Health Risk |
Likely pathogenic |
Cerebral palsy, Cerebral palsy |
| RS2139538797 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS2139545313 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS2139545657 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139546760 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2139547046 |
TPP2
|
Health Risk |
Likely pathogenic |
Evans syndrome, immunodeficiency |
| RS2139552020 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS2139552522 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral palsy, Porencephaly 2 |
| RS2139553210 |
COL4A2
|
Health Risk |
Likely pathogenic |
Porencephaly 2, Intraventricular hemorrhage |
| RS2139553655 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2139555125 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139555500 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139555775 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS2139558301 |
COL4A2
|
Health Risk |
Likely pathogenic |
Porencephaly 2, Porencephaly 2 |
| RS2139560751 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139560811 |
SPTB
|
Health Risk |
Pathogenic |
Elliptocytosis 3, Elliptocytosis 3 |
| RS2139561056 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139567892 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139568866 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139568919 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS2139569112 |
AP4S1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2139581674 |
DNAAF2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2139584419 |
DNAAF2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 10, Primary ciliary dyskinesia 10 |
| RS2139587357 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139591243 |
DNAJC3
|
Health Risk |
Pathogenic |
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome, Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome |
| RS2139591770 |
TMEM260
|
Health Risk |
Pathogenic |
— |
| RS2139592237 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139592956 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139593716 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139593958 |
ALDH18A1
|
Health Risk |
Likely pathogenic |
de Barsy syndrome, Autosomal dominant spastic paraplegia type 9 |
| RS2139594261 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139596055 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139596180 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139596300 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139596820 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139597781 |
NALCN
|
Health Risk |
Pathogenic |
Congenital contractures of the limbs and face, hypotonia |
| RS2139602480 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139602589 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139603257 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139604219 |
YY1
|
Health Risk |
Likely pathogenic |
— |
| RS2139604254 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS2139605753 |
YY1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gabriele de Vries syndrome, Intellectual disability |
| RS2139605757 |
YY1
|
Health Risk |
Pathogenic |
— |
| RS2139605768 |
YY1
|
Health Risk |
Pathogenic |
— |
| RS2139605785 |
YY1
|
Health Risk |
Likely pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS2139605796 |
YY1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS2139605815 |
YY1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2139605856 |
YY1
|
Health Risk |
Likely pathogenic |
— |
| RS2139606980 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2139609624 |
CDC42BPB
|
Health Risk |
Pathogenic |
— |
| RS2139612433 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS2139613030 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139613101 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139621075 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139621272 |
ALDH18A1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 9A, Hereditary spastic paraplegia 9A |
| RS2139621988 |
ALDH18A1
|
Health Risk |
Pathogenic |
ALDH18A1-related de Barsy syndrome, ALDH18A1-related de Barsy syndrome |
| RS2139622959 |
ZEB1
|
Health Risk |
Likely pathogenic |
Posterior polymorphous corneal dystrophy 1, Posterior polymorphous corneal dystrophy 1 |
| RS2139626950 |
TMEM260
|
Health Risk |
Likely pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS2139628261 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139628331 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2139628344 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2139628367 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139628382 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2139628524 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2139628604 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2139628826 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139629943 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2139632228 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2139632398 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2139640370 |
NAXD
|
Health Risk |
Likely pathogenic |
NAD(P)HX dehydratase deficiency, NAD(P)HX dehydratase deficiency |
| RS2139642530 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2139642879 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALDH18A1-related de Barsy syndrome, Hereditary spastic paraplegia 9A |
| RS2139643358 |
DNAJC3
|
Health Risk |
Pathogenic |
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome, Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome |
| RS2139645825 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |